These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7370173)

  • 1. The quantification and significance of mast cells in lesions of Behçet's disease.
    Lichtig C; Haim S; Hammel I; Friedman-Birnbaum R
    Br J Dermatol; 1980 Mar; 102(3):255-9. PubMed ID: 7370173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells in Behçet's disease: ultrastructural and histamine content studies.
    Lichtig C; Haim S; Gilhar A; Hammel I; Ludatscher R
    Dermatologica; 1981; 162(3):167-74. PubMed ID: 7250460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of bcl-2 protein in active skin lesions of Behçet's disease.
    Senturk N; Yildiz L; Sullu Y; Kandemir B; Turanli AY
    Int J Dermatol; 2001 Dec; 40(12):747-50. PubMed ID: 11903667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin hyperreactivity response (pathergy) in Behçet's disease.
    Gilhar A; Winterstein G; Turani H; Landau J; Etzioni A
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):547-52. PubMed ID: 2778116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome.
    Inaloz HS; Evereklioglu C; Unal B; Kirtak N; Eralp A; Inaloz SS
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):56-61. PubMed ID: 14678533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of lesions in Behçet's disease.
    Haim S
    Dermatologica; 1979; 158(1):31-7. PubMed ID: 367842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can specific vessel-based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular-based lesions clinically?
    Boyvat A; Heper AO; Koçyiğit P; Erekul S; Gürgey E
    Int J Dermatol; 2006 Jul; 45(7):814-8. PubMed ID: 16863517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behçet's disease with unusual cutaneous lesions.
    Cantini F; Salvarani C; Niccoli L; Senesi C; Truglia MC; Padula A; Olivieri I
    J Rheumatol; 1998 Dec; 25(12):2469-72. PubMed ID: 9858448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Langerhans' cells in Behçet's disease.
    Kohn S; Haim S; Gilhar A; Friedman-Birnbaum R; Nir I
    J Clin Pathol; 1984 Jun; 37(6):616-9. PubMed ID: 6725610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
    Bariş YS; Yildiz L; Sentürk N; Kandemir B
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behçet's syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up.
    Jorizzo JL; Solomon AR; Cavallo T
    Arch Pathol Lab Med; 1985 Aug; 109(8):747-51. PubMed ID: 3839376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histohogical and direct immunofluorescence study of cutaneous hyperreactivity in Behçet's disease.
    Haim S; Sobel JD; Friedman-Birnbaum R; Lichtig C
    Br J Dermatol; 1976 Dec; 95(6):631-6. PubMed ID: 1009009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of T cell lines established from skin lesions of Behçet's disease.
    Mochizuki M; Morita E; Yamamoto S; Yamana S
    J Dermatol Sci; 1997 May; 15(1):9-13. PubMed ID: 9186807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease with unusual cutaneous lesions.
    Aydin F; Senturk N; Yildiz L; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):106-7. PubMed ID: 16405624
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythema nodosum-like lesions in Behçet's disease: a clinicopathological study of 26 cases.
    Misago N; Tada Y; Koarada S; Narisawa Y
    Acta Derm Venereol; 2012 Nov; 92(6):681-6. PubMed ID: 22504656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic manifestation of Behçet's disease.
    Lee ES; Bang D; Lee S
    Yonsei Med J; 1997 Dec; 38(6):380-9. PubMed ID: 9509907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers.
    Jorizzo JL; Abernethy JL; White WL; Mangelsdorf HC; Zouboulis CC; Sarica R; Gaffney K; Mat C; Yazici H; al Ialaan A
    J Am Acad Dermatol; 1995 Jun; 32(6):968-76. PubMed ID: 7751467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histopathology of cutaneous aphtha in Behçet's syndrome].
    Civatte J; Belaïch S
    Ann Dermatol Syphiligr (Paris); 1976; 103(2):134-40. PubMed ID: 1015796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.
    Sun M; Yang P; Yang Y; Ye J
    Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.
    J Rheumatol; 1989 Apr; 16(4):506-11. PubMed ID: 2664172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.